EP3377516
SAMSETNING TIL MEÐHÖNDLUNAR KRABBAMEINS
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
18.11.2016EP published:
15.6.2022EP application number:
16867262.4
EP translation filed:
22.9.2022Grant published:
15.10.2022EPO information:
European Patent Register
Max expiry date:
17.11.2036Expiry date:
17.11.2026Next due date:
30.11.2026
Title in English:
COMPOSITION FOR TREATING CANCERLanguage of the patent:
English
Timeline
Today
18.11.2016EP application
15.6.2022EP Publication
22.9.2022Translation submitted
15.10.2022Registration published
17.11.2026Expires
Owner
Name:
Memorial Sloan Kettering Cancer CenterAddress:
Office of Industrial Affairs 1275 York Avenue, New York, NY 10065, US
Inventor
Name:
SCHEINBERG, David A.Address:
New York, New York 10065, US
Agent
Name:
COSMOVICI INTELLECTUAL PROPERTY SARLAddress:
11 Boulevard Sébastopol, FR
Priority
Number:
201562258134 PDate:
20.11.2015Country:
US
Classification
Categories:
C07K 14/47, C07K 14/82, A61K 39/00, A61P 35/02
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 2.11.2022
Expires: 17.11.2023
Payer: SWIPR AB
Number: 8
Paid: 9.11.2023
Expires: 17.11.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 9.11.2023
Expires: 17.11.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 23.10.2024
Expires: 17.11.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 11.11.2025
Expires: 17.11.2026
Payer: Árnason Faktor ehf.